Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EMA grants Orphan Drug Designation to Saroglitazar Mg for treating patients with PBC

expresspharmaJuly 22, 2021

Tag: EMA , Saroglitazar , PBC , Zydus

PharmaSources Customer Service